Paper - WANFANG MED ONLINE

You Position: Home > Paper

中国2型糖尿病防治指南(2007年版)

( views:311, downloads:4816 )

Author:: No author available

Journal Title:: NATIONAL MEDICAL JOURNAL OF CHINA

Issue:: 18

DOI:: 10.3321/j.issn:0376-2491.2008.18.002

Key Word:: No keyword available

Abstract： @@ 编者按2007年<中国糖尿病防治指南>项目是以"九·五国家糖尿病防治规划纲要"为依据,坚持预防为主的方针,在中华医学会糖尿病学分会主任委员杨文英教授的领导下,组织全国专家制定的.

Reference

[1]中华医学会糖尿病学分会慢性并发症调查组.1991~2000年全国住院糖尿病患者慢性并发症及相关大血管病变回顾性分析[J].2002,(5).
[2]贾伟平,潘洁敏,陈蕾,等.空腹血糖受损切点变化与糖尿病及心脑血管事件风险的关系--上海华阳社区40岁以上人群的随访研究[J].2004,(5).
[3]张波,王金平,杨文英,等.空腹血糖受损诊断标准下调的合理性分析[J].2004,(5).
[4]中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].2004,(3).
[5]刘佩文,陈璐璐,孙晖,等.武汉地区成人代谢综合征患病率及相关因素[J].2006,(5).
[6]金文胜,潘长玉,陆菊明.国际糖尿病联盟与中华糖尿病学会关于代谢综合征定义的比较[J].2006,(3).
[7]张昕,沈水仙,罗飞宏,等.上海市卢湾区青少年2型糖尿病患病率调查[J].2006,(3).
[8]王先令,陆菊明,潘长玉,等.空腹血糖受损诊断标准下调对糖调节受损人群检出率的影响[J].2005,(4).
[9]中国肥胖问题工作组数据汇总分析协作组.我国成人体重指数和腰围对相关疾病危险因素异常的预测价值：适宜体重指数和腰围切点的研究[J].2002,(1).
[10]卢伟,刘美霞,李锐,等.上海15~74岁居民代谢综合征的流行特征[J].2006,(4).
[11]李岩,赵冬,王薇,等.中国11省市35~64岁人群应用不同代谢综合征诊断标准的比较[J].2007,(1).
[12]Gerstein HC,Yusuf S,Bosch J,etc.Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.[J].2006,368(9541).
[13]James M. Malone,Martin Snyder,Gary Anderson,etc.Prevention of amputation by diabetic education[J].1989,158(6).
[14]Handberg EM,Garcia Barreto D,Bristol HA,etc.A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.[J].2003,290(21).
[15]Baron MA,Purkayastha D,Raskin P,etc.PRESERVE-{beta}: Two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin.[J].2005,28(9).
[16]Carruthers SG,Menard J,Wedel H,etc.Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group (see comments)[J].1998,351(9118).
[17].Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group (see comments) (published erratum appears in Lancet 1998 Nov 7; 352(9139):155[J].1998,352(9131).
[18]Knowler WC,Barrett Connor E,Fowler SE,etc.Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.[J].2002,346(6).
[19]Bergman SA.Perioperative management of the diabetic patient.[J].2007,103(6).
[20]Arner P.,Gunnarsson R.,Blomdahl S.,etc.Some Characteristics of Steroid Diabetes: A Study in Renal-Transplant Recipients Receiving High-Dose Corticosteroid Therapy[J].1983.
[21]Schaper NC.Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies.[J].2004,20(Suppl.1).
[22]B, Richter,G, Neises.'Human' insulin versus animal insulin in people with diabetes mellitus.[J].2002,(3).
[23]Verwaest C,Bouillon R,Lauwers P,etc.Intensive insulin therapy in the surgical intensive care unit.[J].2001,345(19).
[24]Lustman PJ,Anderson RJ,Clouse RE,etc.The prevalence of comorbid depression in adults with diabetes: a meta-analysis.[J].2001,24(6).
[25]Carr, Andrew,Samaras, Katharine,Thorisdottir, Anna,etc.Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study.[J].1999,353(9170).
[26]John A, Colwell.Aspirin therapy in diabetes.[J].2004,27 Suppl 1.
[27]Yasuo Ohkubo,Hideki Kishikawa,Eiichi Araki,etc.Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study[J].1995,28(2).
[28]Rohlfing CurtL,Little RandieR,England JackD,etc.Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial.[J].2002,25(2).
[29].Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators (see comments)[J].2000,355(9200).
[30]Belder R,McCabe CH,Hill KA,etc.Intensive versus moderate lipid lowering with statins after acute coronary syndromes.[J].2004,350(15).
[31]Charlton Menys V,Neil HA,Mackness MI,etc.Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.[J].2004,364(9435).
[32]Wahlen J,Jain R,Wahl T,etc.Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).[J].2006,8(1).
[33]Lindholm LarsH,Ibsen Hans,Kjeldsen SverreE,etc.Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.[J].2002,359(9311).
[34]Sifuentes Osornio J,Olaiz Fernandez G,Rojas R,etc.Tuberculosis and diabetes in southern Mexico.[J].2004,27(7).
[35]Garber A,Hu P,Lewin A,etc.Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.[J].2005,28(2).
[36]《中国糖尿病防治指南》编写组主编.中国糖尿病防治指南[M].2004.
[37]Foley JE,Fonseca V,Gupta S,etc.Addition of nateglinide to rosiglitazone monotherapy suppresses mealtime hyperglycemia and improves overall glycemic control.[J].2003,26(6).
[38]Marks JB.Perioperative management of diabetes.[J].2003,67(1).
[39]J, Carolan.Insulin versus oral agents for 'steroid-induced' diabetes.[J].1999,105(5).
[40].Photocoagulation for Diabetic Macular Edema[J].1985.
[41]Jennifer A, Mayfield,Gayle E, Reiber,Lee J, Sanders,etc.Preventive foot care in diabetes.[J].2004,27 Suppl 1.
[42]Rosenstock J,Gerich J,Riddle MC.The Treat-to-Target Trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.[J].2003,26(11).
[43]D M, Black,A T, Filak.Hyperglycemia with non-insulin-dependent diabetes following intraarticular steroid injection.[J].1989,28.
[44]Pierre-Jean, Guillausseau,Riad, Farah,Marie, Laloi-Michelin,etc.[Urinary tract infections and diabetes mellitus].[J].2003,53(16).
[45]A, Siebenhofer,J, Plank,A, Berghold,etc.Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.[J].2004,(2).
[46]A N, Goudswaard,N J, Furlong,G E H M, Rutten,etc.Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus.[J].2004,(4).
[47]Whitlock G,Parag V,Suh I,etc.Blood glucose and risk of cardiovascular disease in the Asia Pacific region.[J].2004,27(12).
[48]P, Mu?e?eanu,S, Fica,E, Gudovan.New insights in steroid diabetes.[J].1991,29.
[49]Byron J, Hoogwerf.Perioperative management of diabetes mellitus: how should we act on the limited evidence?[J].2006,73 Suppl 1.
[50]M, Merta,R, Rysavá,V, Tesar.[Urinary tract infection in patients with diabetes mellitus].[J].2006,52(5).
[51]J A, Colwell.Aspirin therapy in diabetes.[J].1997,20.
[52]Shari, Bolen,Leonard, Feldman,Jason, Vassy,etc.Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus.[J].2007,147(6).
[53].Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings.[J].1978,85(1).
[54]Girman CJ,Schmidt MI,East HE,etc.The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study.[J].2005,28(2).
[55]Genuth SM,Raskin P,Nathan DM,etc.Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.[J].2005,353(25).
[56].Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group.[J].1998,317.
[57]P, Pozzilli,R D, Leslie.Infections and diabetes: mechanisms and prospects for prevention.[J].1994,11(10).
[58].Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.[J].1998,317.
[59]J E, Patterson,V T, Andriole.Bacterial urinary tract infections in diabetes.[J].1997,11(3).
[60]Hoogwerf BJ.Postoperative management of the diabetic patient.[J].2001,85(5).
[61]M, Backonja,A, Beydoun,K R, Edwards,etc.Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.[J].1998,280.
[62].Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)[J].1994,344.
[63]Mitch WE,Brenner BM,Remuzzi G,etc.Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.[J].2001,345(12).
[64]Fritsche A,Lin Z,Massi Benedetti M,etc.Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes.[J].2005,28(4).
[65]LaRosa JC,Grundy SM,Shear C,etc.Intensive lipid lowering with atorvastatin in patients with stable coronary disease.[J].2005,352(14).
[66]Weinstein RL,McGill JB,Mudaliar SR,etc.Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.[J].2003,26(9).
[67].Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.[J].1998,352.